Domača stranAMBI • NYSEAMERICAN
add
Ambipar Emergency Response
Prejšnji trg. dan.
0,43 $
Dnevni razpon
0,36 $ - 0,42 $
Letni razpon
0,20 $ - 0,55 $
Tržna kapitalizacija
23,01 mio. USD
Povprečni obseg
5,39 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NYSEAMERICAN
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (BRL) | dec. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 817,26 mio. | 10,36 % |
Stroški poslovanja | −21,56 mio. | −262,28 % |
Čisti dohodek | −99,58 mio. | −226,98 % |
Čista dobičkovnost prihodkov | −12,18 | −196,35 % |
Earnings per share | — | — |
EBITDA | 138,17 mio. | −17,75 % |
Efektivna davčna stopnja | −34,76 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (BRL) | dec. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 358,43 mio. | −15,32 % |
Skupna sredstva | 5,80 mrd. | 34,60 % |
Skupne obveznosti | 3,98 mrd. | 34,93 % |
Celoten lastniški kapital | 1,82 mrd. | — |
Shares outstanding | 55,43 mio. | — |
Razmerje P/B | 0,02 | — |
Donosnost sredstev | 3,94 % | — |
Donosnost kapitala | 4,63 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (BRL) | dec. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −99,58 mio. | −226,98 % |
Denar iz dejavnosti | 110,44 mio. | 35,69 % |
Denar iz naložb | 77,48 mio. | 184,48 % |
Denar iz financiranja | −381,16 mio. | −157,73 % |
Neto sprememba denarnih sredstev | −82,47 mio. | 5,91 % |
Prost denarni tok | −260,36 mio. | −2.494,33 % |
Vizitka
Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013, and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange. Wikipedia
Datum ustanovitve
1. jan. 2000
Sedež organizacije
Spletno mesto
Zaposleni
53
